Actively Recruiting
Study of High-Dose Aflibercept 8mg Treatment for New Polypoidal Choroidal Vasculopathy Using Personalized Intervals
Led by Yeungnam University College of Medicine · Updated on 2026-02-05
50
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of high-dose aflibercept 8 mg given in a personalized treatment plan for people with treatment-naive Polypoidal Choroidal Vasculopathy PCV. This study focuses on adjusting the treatment schedule based on individual response, allowing injection intervals to vary from 8 to 24 weeks. The goal is to find the best dosing interval while monitoring disease activity and vision outcomes. All participants receive an initial loading injection of aflibercept 8 mg. After 4 weeks, their response is checked. If the polyp has fully regressed and there is no sign of disease, the treatment interval is extended to 8 weeks. Those with active disease continue monthly injections up to three doses before starting a treat-and-extend phase where injection intervals may be lengthened or shortened by 4 weeks. Intervals are adjusted based on disease activity and fluid levels, with a minimum of 8 weeks and a maximum of 24 weeks between injections. Participants will have regular eye examinations including imaging to assess polyp regression, visual acuity, and retinal thickness. Researchers will monitor how many patients reach injection intervals of 16 weeks or longer by week 96. Safety is tracked by recording treatment-related side effects. The study lasts at least 96 weeks, during which participants attend scheduled visits for treatment and assessments to measure vision and eye health changes over time.
CONDITIONS
Brief Title
Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial
Research Team
S
Sohee Shin
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here